Osteoarthritis: Causes, Root Drivers & What Helps

Osteoarthritis (OA) is the most common form of arthritis in the world, and for decades it was explained in one phrase: "wear and tear." That framing is not wrong, since load and injury do matter, but it is incomplete. Research now describes OA as a disease of the whole joint: cartilage, bone, synovium, ligaments and the fat pad. Low-grade inflammation, metabolic health and hormones all play a part. This page goes through what OA is, who gets it, the conventional and root-cause explanations, how it is diagnosed, and which interventions have the best evidence. Every major claim carries a grade.

Important: This page is general educational information, not medical advice. Joint pain has many causes, and some need urgent treatment. Always consult a qualified healthcare professional before changing your diet, supplements, exercise, or medication, and never stop a prescribed medication without speaking to the prescribing physician.

Key takeaways

  • OA affects an estimated 595 million people worldwide (2020), and the number of cases has more than doubled since 1990. Strong
  • OA is a whole-joint disease with frequent low-grade synovial inflammation, not purely mechanical erosion. Strong
  • Obesity raises OA risk through load and metabolism. It is linked even to hand OA, which carries no body weight. Strong
  • A distinct "metabolic OA" phenotype driven by insulin resistance, adipokines and inflammaging is a plausible, active research area. Emerging
  • Exercise therapy and weight loss (when overweight) are first-line, strongly recommended treatments in ACR, OARSI and NICE guidelines. Strong
  • Popular supplements (glucosamine, chondroitin, vitamin D) have weak or mixed evidence for OA. Contested

What is osteoarthritis? Strong

Osteoarthritis is a chronic joint disease in which the smooth articular cartilage that caps the ends of bones gradually breaks down. The bone beneath it (the subchondral bone) remodels and stiffens, bony spurs (osteophytes) form at the joint margins, and the joint lining (synovium) often becomes mildly inflamed. The result is pain, stiffness, and reduced movement. OA most often affects the knees, hips, hands (especially the base of the thumb and finger end-joints), and spine.13

OA is different from inflammatory arthritis such as rheumatoid arthritis (RA), which is an autoimmune disease with high systemic inflammation, prolonged morning stiffness and characteristic antibodies. OA inflammation is low-grade and local. The distinction matters because the treatments are very different. For the broader picture across arthritis types, see the root causes of arthritis.

How common is osteoarthritis? Strong

595MPeople with OA worldwide in 2020 (7.6% of the population)
+132%Rise in total cases since 1990
365MPeople with knee OA, the most affected joint (2019)1
~60%Share of people with OA who are women

The Global Burden of Disease study estimated that 595 million people had OA in 2020, equal to 7.6% of the global population, an increase of about 132% in total cases since 1990. It projected further steep increases by 2050 for knee, hip and hand OA. The study also attributed about one-fifth of OA disability to high body-mass index.4 The World Health Organization reports that about 73% of people living with OA are older than 55, about 60% are women, and the knee is the most frequently affected joint, followed by the hip and hand.1 In the United States, the CDC estimates that OA affects about 33 million adults.2

Population aging explains part of this rise. Rising obesity and less physical activity explain more, and those two factors are also the most modifiable.

Conventional vs. root-cause framing

Conventional framing

  • OA as "wear and tear": cumulative mechanical damage to cartilage with age.
  • Focus on the joint: imaging grade, pain control, and eventually joint replacement.
  • Treatment ladder: education, exercise, weight management, then analgesics, NSAIDs, injections, surgery.
  • Mechanical risk (injury, alignment, occupation) is front and center.

Root-cause framing

  • OA as a whole-joint, low-grade inflammatory disease ("osteoarthritis is not osteoarthrosis").
  • Joints sit inside a body: visceral fat, insulin resistance, and inflammaging shape the joint environment.
  • Phenotypes: post-traumatic, age-related, metabolic, and hormone-related OA.
  • Upstream levers: body composition, muscle strength, diet quality, sleep, and metabolic health.

The two views are more complementary than opposed. Mainstream rheumatology already accepts that inflammation and metabolic factors contribute to OA.1112 Where root-cause writers go further, for example by treating OA mainly as a dietary or gut problem, the evidence becomes thinner, and we flag that below.

The root drivers of osteoarthritis

Low-grade synovitis Strong (common, linked to pain) Emerging (as a driver)

MRI and ultrasound studies find synovial inflammation in a large share of people with OA, including early disease. Synovitis is associated with more pain, and in the Multicenter Osteoarthritis Study, knees with more synovitis on MRI (score 3 or more) were about 1.6 times as likely to develop radiographic OA, after adjusting for other joint damage.111220 This inflammation is far milder than in rheumatoid arthritis, and systemic markers such as hs-CRP are usually normal or only slightly raised.

Mechanism: the cartilage–synovium feedback loop

Fragments of damaged cartilage matrix act as damage-associated molecular patterns (DAMPs). They activate innate-immune receptors (such as Toll-like receptors and complement) on synovial cells and macrophages. These cells then release cytokines (IL-1β, TNF-α, IL-6) and cartilage-degrading enzymes (MMPs, ADAMTS aggrecanases), which break down more cartilage and release more fragments, so the loop sustains itself.11

Metabolic OA & inflammaging Emerging

"Metabolic OA" is a proposed phenotype in which metabolic syndrome (central obesity, insulin resistance, dyslipidemia and hypertension) helps drive joint degeneration through systemic pathways.13 Inflammaging refers to the chronic, low-grade inflammation that builds with age as senescent cells accumulate and secrete inflammatory signals (the senescence-associated secretory phenotype). Chondrocytes are long-lived cells and appear especially vulnerable. Both concepts are well grounded in biology. Whether targeting them changes OA outcomes in people is still being tested.

Obesity & adipokines Strong (obesity) Emerging (adipokine mechanisms)

Obesity is one of the strongest modifiable risk factors for knee OA. In the Framingham cohort, women whose body-mass index fell by 2 units or more (about 5 kg) over ten years had more than 50% lower odds of developing symptomatic knee OA.15 Load is part of the story, but obesity is also associated with OA of the hands, which carry no body weight (approximate risk ratio 1.9 in a systematic review, moderate-level evidence).21 This points to systemic effects. Fat tissue, especially visceral fat and the infrapatellar fat pad inside the knee, secretes adipokines such as leptin and resistin, which are thought to promote cartilage breakdown and synovial inflammation; leptin, resistin and adiponectin have all been found in synovial fluid from OA joints.121322 Adiponectin is often described as protective, but inside the joint it may also promote inflammation, so "low adiponectin" is not a simple explanation.22 See the metabolic dysfunction section of our root-causes page for the AGE/RAGE pathway.

Insulin resistance & hyperglycemia Emerging

Type 2 diabetes and insulin resistance have been associated with OA and with worse OA pain in several studies, but it is hard to separate their effect from body weight, and the findings are mixed.13 Proposed mechanisms include advanced glycation end-products (AGEs) that stiffen cartilage collagen, direct effects of high glucose on chondrocytes, and insulin resistance in synovial tissue. You can follow your own metabolic picture with fasting insulin and HOMA-IR. Refined sugar and ultra-processed foods, the main dietary contributors, are covered on foods that may worsen arthritis.

Estrogen & menopause Strong (association) Emerging (mechanism) Contested (HRT as treatment)

OA is more common in women, and its prevalence rises sharply around menopause. Hand OA is the clearest example.1 Cartilage, bone and synovium carry estrogen receptors, and animal studies show cartilage loss after estrogen withdrawal. Human trials of hormone therapy for OA symptoms or structure have not given clear answers, and no guideline recommends hormone therapy to treat OA. Any decision about hormone therapy should be made with a physician, weighing its other benefits and risks. See hormonal imbalances for background.

Joint injury & biomechanics Strong

A previous knee injury, such as an ACL tear or meniscal damage, raises the risk of knee OA about four- to six-fold, according to a 2019 meta-analysis.16 This "post-traumatic OA" often appears 10 to 20 years after the injury, so it can affect people in their 30s and 40s. Malalignment (bow-legs or knock-knees), joint shape abnormalities such as hip dysplasia, quadriceps weakness, and repetitive occupational kneeling or heavy lifting also concentrate load on cartilage.3 Injury-prevention programs and rehabilitation after injury are among the most practical forms of OA prevention.

Vitamins K and D Emerging (vitamin K) Contested (vitamin D supplements)

Vitamin K activates matrix Gla protein, which inhibits cartilage calcification. In a cohort study, people with subclinical vitamin K deficiency were more likely to develop knee OA.17 That is an association, and randomized trials showing benefit from vitamin K supplements are lacking. Low vitamin D is common in people with OA, but a two-year randomized trial found that vitamin D supplementation did not reduce knee pain or slow cartilage loss compared with placebo.18 It is reasonable to correct a confirmed deficiency for general health (see 25-OH vitamin D testing), but do not expect it to treat OA. People on blood thinners such as warfarin must not take vitamin K without their doctor's guidance.

Proposed root drivers of osteoarthritis at a glance
DriverProposed mechanismModifiable?Evidence
Low-grade synovitisDAMP-driven innate immune activation; cytokines and MMPsPartly (weight, activity)Strong association
ObesityJoint load plus adipokines (leptin, resistin)YesStrong
Metabolic syndrome / inflammagingSystemic inflammation, cell senescencePartlyEmerging
Insulin resistanceAGEs, glucose toxicity to chondrocytesYesEmerging
Estrogen declineLoss of cartilage- and bone-protective signalingLimitedEmerging mechanism
Joint injury / malalignmentAbnormal load, post-traumatic cascadePartly (prevention, rehab)Strong
Vitamin K statusUnder-carboxylated MGP, cartilage calcificationYesEmerging
Vitamin D statusBone and immune effectsYesContested

Symptoms Strong

  • Activity-related joint pain that worsens with use and eases with rest, at least early on.
  • Short-lived stiffness in the morning or after sitting, usually under 30 minutes. Longer stiffness suggests an inflammatory arthritis.
  • Reduced range of motion and difficulty with stairs, rising from a chair, gripping, or opening jars.
  • Crepitus: grating, cracking or crunching sensations.
  • Bony enlargement, such as Heberden's and Bouchard's nodes on the finger joints.14
  • Mild swelling or effusion, and occasionally a feeling of the joint "giving way."

Pain and imaging do not always agree. Some people with marked X-ray changes have little pain, and others have significant pain with mild changes. Pain in OA also involves the nervous system (central sensitization), sleep, mood, and muscle strength, which is one reason exercise and sleep help.3 For sleep and stress, see lifestyle & toxins.

Risk factors

Osteoarthritis risk factors
Risk factorTypeNotesEvidence
Older ageNon-modifiableMost cases occur after 55. Cartilage repair capacity and muscle mass decline.Strong
Female sexNon-modifiableAbout 60% of cases. Risk rises steeply around menopause.Strong
Genetics / family historyNon-modifiableEspecially hand and hip OA. Many genes, each with a small effect.Strong
ObesityModifiableKnee risk especially. Also linked to hand OA through metabolic pathways.Strong
Previous joint injuryPartly modifiableAbout 4–6× knee OA risk after a knee injury.Strong
Occupational loadModifiableRepetitive kneeling, squatting, heavy lifting.Strong
Muscle weaknessModifiableQuadriceps weakness is linked to knee OA pain and disability; in a meta-analysis of 5 cohorts, weaker knee extensors raised the odds of developing symptomatic knee OA (OR 1.65).23Strong
Joint malalignment / dysplasiaPartly modifiableConcentrates load on one compartment of the joint.Strong
Metabolic syndrome / type 2 diabetesModifiableAssociation partly independent of weight. Studies are mixed.Emerging
Recreational runningNot a risk factor for most peopleRecreational running has not been shown to raise knee OA risk in people without prior injury.Emerging

Diagnosis Strong

Full guide: Rheumatoid arthritis vs osteoarthritis — how to tell them apart: joint patterns, morning stiffness and blood tests.

OA is usually diagnosed clinically, from symptoms and examination. The UK NICE guideline (NG226) says clinicians can diagnose OA without imaging in people aged 45 or over who have activity-related joint pain and either no morning stiffness or morning stiffness lasting 30 minutes or less.7

  • X-rays show joint-space narrowing, osteophytes and subchondral sclerosis, often graded with the Kellgren–Lawrence scale.19 They help when the picture is atypical or surgery is being considered.
  • MRI shows cartilage, bone marrow lesions and synovitis, but is not needed routinely.
  • Blood tests do not diagnose OA. They are used to rule out other conditions, such as rheumatoid arthritis (anti-CCP, RF), gout (uric acid), or infection. Markedly raised CRP/ESR points away from OA.
  • Joint aspiration may be done for a swollen joint to exclude crystals or infection.

Evidence-graded interventions

The ACR/Arthritis Foundation, OARSI and NICE guidelines agree on the core: education, exercise, and weight management for everyone with OA, with medicines and procedures added as needed.567 These core measures also act on the root drivers above.

Weight loss Strong

For people with overweight or obesity and knee or hip OA, weight loss is strongly recommended.5 Biomechanical research found that each pound (about 0.45 kg) of weight lost removes roughly four pounds of load from the knee with every step.9 In the IDEA randomized trial, older adults with knee OA who combined diet and exercise lost about 11% of body weight on average and had the greatest improvements in pain and function. Knee compressive forces were lower in the diet-only group than with exercise alone, and both diet groups had lower IL-6.10 Guidelines generally note benefit from a loss of 5% or more, with larger losses giving larger gains.

Practical tip: Combining dietary change with exercise outperforms either alone. Prioritize protein and strength training while losing weight, so you keep the muscle that supports the joint. If you are considering weight-loss medication or surgery, discuss it with your physician.

Exercise therapy Strong

A Cochrane review of 54 trials found that land-based therapeutic exercise reduces knee OA pain and improves physical function, with benefits comparable in size to those reported for NSAIDs.8 The ACR guideline strongly recommends exercise for knee, hip and hand OA, and specifically strongly recommends tai chi for knee and hip OA.5 Exercise is safe for arthritic joints. It does not "wear them out" faster.

  • Strengthening: quadriceps, hip abductors and gluteal muscles for knee and hip OA; grip and thumb exercises for hand OA.
  • Aerobic: walking, cycling, swimming or water-based exercise.
  • Mind-body: tai chi, and yoga for knee OA.
  • Structured programs led by a physical therapist improve adherence. Some discomfort during exercise is acceptable if it settles within about 24 hours.

Diet Strong (as a weight-loss tool) Emerging (anti-inflammatory effects)

The strongest dietary evidence in OA is for calorie reduction that leads to weight loss.10 Beyond that, Mediterranean-style eating patterns rich in vegetables, legumes, oily fish, extra-virgin olive oil and whole foods are biologically plausible ways to lower systemic inflammation and improve insulin sensitivity. Trials specific to OA are still limited and small. Our anti-inflammatory diet plan covers the details, and foods to avoid covers sugar, refined carbohydrates and ultra-processed foods.

Supplements and medications

Common OA treatments and the strength of evidence
OptionWhat guidelines sayEvidence
Exercise therapyStrongly recommended, first line (knee, hip, hand)Strong
Weight loss (if overweight)Strongly recommended (knee, hip)Strong
Topical NSAIDsStrongly recommended for knee OA (ACR)Strong
Oral NSAIDsRecommended at lowest effective dose and shortest duration. GI, kidney and cardiovascular risks apply.Strong (symptom relief)
Intra-articular corticosteroidRecommended for short-term relief (knee, hip)Strong (short-term)
Canes, braces, thumb splintsRecommended in specific situationsStrong
Turmeric / curcuminNot addressed as a core therapy. Small trials suggest modest pain benefit.Emerging
GlucosamineACR strongly recommends against for knee, hip and hand OAContested
ChondroitinStrongly recommended against for knee and hip; conditionally recommended for hand OA (ACR)Contested
Vitamin D, fish oilConditionally recommended against for OA (ACR)Contested

Our medications page discusses the NSAID paradox and the effects of long-term corticosteroids. Treatment decisions, including starting, changing, or stopping any medicine, belong with your physician.

Dietary & supplement note: Statements here about nutrients and dietary supplements have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease.

When to see a doctor

Seek urgent medical care for a joint that is suddenly hot, red and swollen, especially with fever or feeling unwell, since this can be septic arthritis or gout. Also seek urgent care if you cannot bear weight after an injury, if a joint is visibly deformed, or if joint pain comes with numbness, weakness, or loss of bladder or bowel control.

Book a routine appointment with your doctor if you have:

  • Joint pain or stiffness lasting more than a few weeks, or pain that limits work, sleep or daily activities.
  • Morning stiffness lasting longer than 30–60 minutes, swelling in several joints, or symmetrical small-joint involvement. These can signal an inflammatory arthritis that benefits from early treatment.
  • Unexplained weight loss, fatigue, rash, or eye inflammation together with joint pain.
  • Pain that is getting worse despite exercise and weight management, or side effects from pain medicines.

A doctor or physical therapist can confirm the diagnosis, rule out other causes, and build a plan. If you already take medicines for OA or another condition, keep taking them as prescribed while you explore the lifestyle measures on this page.

Frequently asked questions

Is osteoarthritis just wear and tear?

Not entirely. Mechanical load and joint injury matter, but research now describes OA as a disease of the whole joint, with low-grade inflammation of the synovium and metabolic factors such as obesity-related adipokines contributing. Obesity is linked even to hand OA, which is not weight-bearing. This is educational information, not medical advice.

Can losing weight help knee osteoarthritis?

Yes. For people with overweight or obesity, weight loss is strongly recommended by major guidelines. Each pound lost removes roughly four pounds of load from the knee per step, and losses of 10% or more of body weight in trials improved pain and function. Talk to your doctor about a safe plan.

Should I exercise if my joints hurt from osteoarthritis?

For most people, yes. Exercise therapy, including strengthening, aerobic activity, and tai chi, is a first-line, strongly recommended treatment for knee and hip OA and reduces pain and improves function. A physical therapist can tailor a program. Seek medical advice for a hot, red, or suddenly swollen joint.

How is osteoarthritis diagnosed?

Often clinically. UK NICE guidance says OA can be diagnosed without imaging in people aged 45 or over who have activity-related joint pain and either no morning stiffness or stiffness lasting 30 minutes or less. X-rays and blood tests are mainly used to rule out other conditions.

Do glucosamine, chondroitin, or vitamin D help osteoarthritis?

The evidence is weak or mixed. The 2019 ACR/Arthritis Foundation guideline strongly recommends against glucosamine for knee, hip and hand OA, and a two-year trial of vitamin D supplementation did not slow knee pain or cartilage loss. Discuss any supplement with your physician.

References

  1. Osteoarthritis — fact sheet. World Health Organization. who.int/news-room/fact-sheets/detail/osteoarthritis
  2. Osteoarthritis — Arthritis. Centers for Disease Control and Prevention (CDC). cdc.gov/arthritis/osteoarthritis
  3. Osteoarthritis — National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH. niams.nih.gov/health-topics/osteoarthritis
  4. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050. Lancet Rheumatology, 2023. doi.org/10.1016/S2665-9913(23)00163-7 PubMed 37675071
  5. Kolasinski SL, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care & Research, 2020. doi.org/10.1002/acr.24131 PubMed 31908149
  6. Bannuru RR, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and Cartilage, 2019. doi.org/10.1016/j.joca.2019.06.011 PubMed 31278997
  7. Osteoarthritis in over 16s: diagnosis and management (NG226). National Institute for Health and Care Excellence (NICE), 2022. nice.org.uk/guidance/ng226
  8. Fransen M, et al. Exercise for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2015. doi.org/10.1002/14651858.CD004376.pub3 PubMed 25569281
  9. Messier SP, et al. Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis & Rheumatism, 2005. doi.org/10.1002/art.21139 PubMed 15986358
  10. Messier SP, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA, 2013. doi.org/10.1001/jama.2013.277669 PubMed 24065013
  11. Robinson WH, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nature Reviews Rheumatology, 2016. doi.org/10.1038/nrrheum.2016.136 PubMed 27539668
  12. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis and Cartilage, 2013. doi.org/10.1016/j.joca.2012.11.012 PubMed 23194896
  13. Zhuo Q, et al. Metabolic syndrome meets osteoarthritis. Nature Reviews Rheumatology, 2012. doi.org/10.1038/nrrheum.2012.135 PubMed 22907293
  14. Alexander CJ. Heberden's and Bouchard's nodes. Annals of the Rheumatic Diseases, 1999;58(11):675–678. PubMed 10531070
  15. Felson DT, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women: the Framingham Study. Annals of Internal Medicine, 1992. doi.org/10.7326/0003-4819-116-7-535 PubMed 1543306
  16. Poulsen E, et al. Knee osteoarthritis risk is increased 4–6 fold after knee injury: a systematic review and meta-analysis. British Journal of Sports Medicine, 2019. doi.org/10.1136/bjsports-2018-100022 PubMed 31072840
  17. Misra D, et al. Vitamin K deficiency is associated with incident knee osteoarthritis. American Journal of Medicine, 2013. doi.org/10.1016/j.amjmed.2012.10.011 PubMed 23410565
  18. McAlindon T, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA, 2013. doi.org/10.1001/jama.2012.164487 PubMed 23299607
  19. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Annals of the Rheumatic Diseases, 1957. doi.org/10.1136/ard.16.4.494 PubMed 13498604
  20. Felson DT, Niu J, Neogi T, et al. Synovitis and the risk of knee osteoarthritis: the MOST Study. Osteoarthritis and Cartilage, 2016;24(3):458–464. PubMed 26432512
  21. Yusuf E, Nelissen RG, Ioan-Facsinay A, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Annals of the Rheumatic Diseases, 2010;69(4):761–765. PubMed 19487215
  22. Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Current Medicinal Chemistry, 2007;14(10):1095–1100. PubMed 17456023
  23. Øiestad BE, Juhl CB, Eitzen I, Thorlund JB. Knee extensor muscle weakness is a risk factor for development of knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis and Cartilage, 2015;23(2):171–177. PubMed 25450853